Company: DRTSW
Filing Date: 2025-06-23
Form Type: F-3
Source: 0001213900-25-056744
Chunk: 52

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-06-23
Form: F-3
Chunk 52
---
7, 2022, as updated by the description of our ordinary shares that served as Exhibit 2.1 to our Annual Report on Form 20-F for the 
 fiscal year ended December 31, 2024 filed with the SEC on March 12, 2025; and                                                                                                                              |

All reports and other documents
we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of this offering, including
all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the
registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference
into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. We may also incorporate
by reference part or all of any reports on Form 6-K that we subsequently furnish to the SEC prior to the completion or termination of
any offering by identifying in such Forms 6-K that such Form 6-K, or certain parts or exhibits of such Form 6-K, are being incorporated
by reference into this prospectus, and any Form 6-K (or parts thereof) so identified shall be deemed to be incorporated by reference in
this prospectus and to be a part of this prospectus from the date of submission of such document.

We have filed a registration
statement on Form F-3 to register the issuance and the resale of the securities described elsewhere in this prospectus. This prospectus
is a part of that registration statement. As permitted by SEC rules, this prospectus does not contain all of the information included
in the registration statement and the accompanying exhibits and schedules we file with the SEC. You may refer to the registration statement
and the exhibits and schedules for more information about us and our securities.

Information and statements
contained in this prospectus or any annex to this prospectus are qualified in all respects by reference to the copy of the relevant contract
or other annex filed as an exhibit to the registration statement of which this prospectus forms a part.

Statements made in this
prospectus concerning the contents of any contract, agreement or other document are not complete descriptions of all terms of these
documents. If a document has been filed as an exhibit to the registration statement, we refer you to the copy of the document that
has been filed for a complete description of its terms. Each statement